SAR 55.9
(2.57%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 45.41 Million SAR | 6.03% |
2022 | 42.83 Million SAR | 7.02% |
2021 | 40.02 Million SAR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 45.61 Million SAR | 0.43% |
2024 Q2 | 45.61 Million SAR | 0.0% |
2023 Q3 | 45.41 Million SAR | 0.24% |
2023 FY | 45.41 Million SAR | 6.03% |
2023 Q1 | 45.31 Million SAR | 5.78% |
2023 Q2 | 45.31 Million SAR | 0.0% |
2023 Q4 | 45.41 Million SAR | 0.0% |
2022 Q4 | 42.83 Million SAR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Middle East Pharmaceutical Industries Co. | 444.89 Million SAR | 89.791% |
Al-Dawaa Medical Services Company | 4.7 Billion SAR | 99.035% |
Nahdi Medical Company | 5.37 Billion SAR | 99.154% |
Almujtama Alraida Medical Co. | 441.99 Million SAR | 89.724% |